“Ageing with HIV” symposium
Over the last three decades, we have witnessed tremendous progress in HIV care. Millions of people all over the world are now living longer with HIV thanks to antiretroviral treatment (ART).
While they are living to older ages, research has shown that these people have a higher risk of developing non-communicable diseases (NCDs). It is more important than ever to include prevention and treatment of NCDs in HIV care.
The Amsterdam Institute for Global Health and Development (AIGHD), the Amsterdam Infection & Immunity Institute and the Amsterdam UMC are hosting a free global health symposium focused on our current understanding of HIV and ageing around the world.
Date and Time: 14:00 on October 15, 2019 (Registration begins at 13:30)
Location: Collegezaal 4 Amsterdam UMC (location AMC)
The symposium will summarize our current understanding of cardiovascular disease and cognitive impairment in those on HIV treatment, as well as projections about the expected future NCD burden in both high- and lower-income settings, and the implications for financing and comprehensive care provision for persons living with HIV.
Speakers include Prof. Serena Spudich from Yale University, Prof. Patrick Mallon from University College Dublin, Dr. Mikaela Smit from Imperial College London, and Prof. Anna Vassall from the Amsterdam Institute for Global Health and Development and the London School of Hygiene and Tropical Medicine.
The symposium is held in honor of PhD candidate Rosan van Zoest, who will defend her thesis on October 16 at 10:00 at the Agnietenkapel.
Full program details are below:
14.00-14.05: Welcome and introduction [Peter Reiss, Amsterdam UMC & Amsterdam Institute for Global Health and Development, Amsterdam]
14.10-14.40: Ageing with HIV: lessons learned [Rosan van Zoest, Amsterdam Institute for Global Health and Development, Amsterdam]
14.40-15.10: Cognitive impairment in HIV in 2019: the knowns and unknowns [Serena Spudich, Yale University]
15.10-15.40: Antiretroviral therapy and its contribution to comorbidity: myths and realities [Patrick Mallon, University College Dublin]
15.40-16.10: The growing comorbidity burden in people living with HIV: expectations and impact [Mikaela Smit, Imperial College, London]
16.10-16.40: Financing comprehensive health care for persons living with HIV in low- and middle-income countries: challenges and opportunities [Anna Vassall, Amsterdam Institute for Global Health and Development, Amsterdam & LSHTM, London]
16.40-17.10: Moderated panel discussion
17.10-17.15: Closing & Drinks [Peter Reiss]
